GlobalData on MSN9d
GSK and University of Oxford partner for cancer vaccine researchGSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme to explore ...
GSK plc (LSE/NYSE: GSK) and the University of Oxford (Oxford) today announced that they have entered a new research ...
Evening Standard on MSN10d
GSK and Oxford researchers to create cancer vaccine to stop disease developingThe partnership intends to create a vaccine or vaccines which target cells at the pre-cancerous stage before the disease has ...
British pharma giant GSK is heading back to school, pledging up to 50 million pounds sterling (about $62.4 million) to work ...
The pharma group has pledged up to £50 million ($62.5 million) in funding over three years for the initiative, which builds ...
Pharmaceutical giant GSK and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or vaccines which target ...
GSK (GSK) and the University of Oxford announced that they have entered a new research collaboration focused on the potential of cancer ...
Professor Sarah Blagden, from the University of Oxford, will co-lead the new GSK-Oxford Cancer Immuno-Prevention Programme, which is backed by £50 million from GSK. She told BBC Radio 4’s Today ...
Pharmaceutical giant GSK and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or vaccines which target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback